Overview

An Open Label Phase II Study of Indisulam in Combination With Irinotecan in Patients With Metastatic Colorectal Cancer Who Have Been Previously Treated With 5-Fluorouracil/Leucovorin and Oxaliplatin

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The overall purpose of this study is to determine the efficacy, safety and tolerability of indisulam in combination with irinotecan as a treatment for patients with metastatic colorectalcancer previously treated with 5-fluorouracil/leucovorin and oxaliplatin (FOLFOX).

Phase:

Phase 2

Details

Lead Sponsor:

Eisai Limited

Treatments:

N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide